Last reviewed · How we verify
NCT03503734: IV
Integrated Care for Migraine and Chronic Tension-type Headaches
trial testing Integrated headache care in Chronic Headache in 158 participants. Completed in 30 January 2014.
30 July 2013
Quick facts
| Lead sponsor | Universität Duisburg-Essen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 158 |
| Start date | 18 August 2011 |
| Primary completion | 30 July 2013 |
| Estimated completion | 30 January 2014 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Integrated headache care
Conditions studied
- Chronic Headache — all drugs for Chronic Headache →
Sponsor
Universität Duisburg-Essen — full company profile →
Who can join
18 and older, any sex, with Chronic Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic headache is among the most common neurological disorders with major physical, psychological, social and economic impact. The aim of this prospective observational study isto investigate the effects of an interdisciplinary multimodal integrated care program in patients with chronic migraine and/or tension-type headache. 158 patients with chronic migraine or tensions-type headache at least five days per month for at least 6 months and current intake of triptans (migraine) or analgesic drugs (tension-type headache) are eligible. Patients undergo inpatient, outpatient and/or semi-stationary treatment including conventional headache diagnostics and therapy as well as traditional Chinese medicine, European naturopathy, and mind-body-medicine approaches. Headache frequency is defined as the primary outcome; secondary outcomes include pain (visual analog scale, Pain Perception Scale), triptans and analgesics use (headache diary), health-related quality of life (SF-36), function (Headache Disability Inventory, Patient-specific Functional Scale), depression and anxiety (Hospital Anxiety and Depression Scale), and pain self-efficacy (Pain Self-Efficacy Questionnaire). Outcomes are assessed at treatment start, treatment end and 6 months after treatment end.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03503734
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Headache
Currently open trials in the same condition.
- NCT06921109 — Assessment of the Effectiveness of Virtual Reality as a Learning Tool for Relaxation Techniques in Reducing Pediatric Mi · NA · recruiting
Other Universität Duisburg-Essen trials
Trials by the same sponsor.
- NCT07273045 — A Comprehensive, Multinational GIST Registry · not yet recruiting
- NCT07255313 — Strengthening Health Literacy in Healthcare Workers Through Mind Body Medicine and Nutrition · NA · recruiting
- NCT05645588 — Pranayama for Posttraumatic Stress Disorder · NA · withdrawn
- NCT06666296 — Sustainable Eating for a Healthy Tomorrow - Effectiveness of Digital Nutrition Workshops to Implement the Planetary Heal · NA · completed
- NCT06204458 — Mild Water-filtered Infrared-A Whole-body Hyperthermia in Patients With Post-COVID Syndrome (HyPoCo) · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03503734 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universität Duisburg-Essen
- Last refreshed: 20 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03503734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing